NCT04253353View on ClinicalTrials.gov

A Drug-Drug Interaction Study To Estimate The Effect Of Tafamidis On Rosuvastatin Pharmacokinetics

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

February 6, 2020

Primary Completion Date

August 10, 2020

Study Completion Date

August 10, 2020

Conditions

Healthy Volunteers

Interventions

DRUG

tafamidis

61 mg capsule

DRUG

rosuvastatin

10 mg tablet

Trial Locations (1)

B-1070

Brussels Clinical Research Unit, Brussels

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT04253353 - A Drug-Drug Interaction Study To Estimate The Effect Of Tafamidis On Rosuvastatin Pharmacokinetics | Biotech Hunter | Biotech Hunter